Rocket Pharmaceuticals' Insider Transactions and Strategic Developments Under Review
Gaurav Shah, CEO of Rocket Pharmaceuticals (NASDAQ:RCKT), recently reported selling a significant block of common stock following the exercise of an option. This transaction occurred alongside other stock movements that highlight insider activity. Separately, the company has secured major strategic wins, including the sale of its Rare Pediatric Dis…